• Je něco špatně v tomto záznamu ?

Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity

F. Zahedifard, M. Bansal, N. Sharma, S. Kumar, S. Shen, P. Singh, B. Rathi, M. Zoltner

. 2024 ; 18 (3) : e0012050. [pub] 20240325

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014543

Pharmacophores such as hydroxyethylamine (HEA) and phthalimide (PHT) have been identified as potential synthons for the development of compounds against various parasitic infections. In order to further advance our progress, we conducted an experiment utilising a collection of PHT and HEA derivatives through phenotypic screening against a diverse set of protist parasites. This approach led to the identification of a number of compounds that exhibited significant effects on the survival of Entamoeba histolytica, Trypanosoma brucei, and multiple life-cycle stages of Leishmania spp. The Leishmania hits were pursued due to the pressing necessity to expand our repertoire of reliable, cost-effective, and efficient medications for the treatment of leishmaniases. Antileishmanials must possess the essential capability to efficiently penetrate the host cells and their compartments in the disease context, to effectively eliminate the intracellular parasite. Hence, we performed a study to assess the effectiveness of eradicating L. infantum intracellular amastigotes in a model of macrophage infection. Among eleven L. infantum growth inhibitors with low-micromolar potency, PHT-39, which carries a trifluoromethyl substitution, demonstrated the highest efficacy in the intramacrophage assay, with an EC50 of 1.2 +/- 3.2 μM. Cytotoxicity testing of PHT-39 in HepG2 cells indicated a promising selectivity of over 90-fold. A chemogenomic profiling approach was conducted using an orthology-based method to elucidate the mode of action of PHT-39. This genome-wide RNA interference library of T. brucei identified sensitivity determinants for PHT-39, which included a P-type ATPase that is crucial for the uptake of miltefosine and amphotericin, strongly indicating a shared route for cellular entry. Notwithstanding the favourable properties and demonstrated efficacy in the Plasmodium berghei infection model, PHT-39 was unable to eradicate L. major infection in a murine infection model of cutaneous leishmaniasis. Currently, PHT-39 is undergoing derivatization to optimize its pharmacological characteristics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014543
003      
CZ-PrNML
005      
20240905134103.0
007      
ta
008      
240725s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pntd.0012050 $2 doi
035    __
$a (PubMed)38527083
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zahedifard, Farnaz $u Drug Discovery and Evaluation Unit, Department of Parasitology, Faculty of Science, Charles University in Prague, Biocev, Vestec, Czech Republic
245    10
$a Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity / $c F. Zahedifard, M. Bansal, N. Sharma, S. Kumar, S. Shen, P. Singh, B. Rathi, M. Zoltner
520    9_
$a Pharmacophores such as hydroxyethylamine (HEA) and phthalimide (PHT) have been identified as potential synthons for the development of compounds against various parasitic infections. In order to further advance our progress, we conducted an experiment utilising a collection of PHT and HEA derivatives through phenotypic screening against a diverse set of protist parasites. This approach led to the identification of a number of compounds that exhibited significant effects on the survival of Entamoeba histolytica, Trypanosoma brucei, and multiple life-cycle stages of Leishmania spp. The Leishmania hits were pursued due to the pressing necessity to expand our repertoire of reliable, cost-effective, and efficient medications for the treatment of leishmaniases. Antileishmanials must possess the essential capability to efficiently penetrate the host cells and their compartments in the disease context, to effectively eliminate the intracellular parasite. Hence, we performed a study to assess the effectiveness of eradicating L. infantum intracellular amastigotes in a model of macrophage infection. Among eleven L. infantum growth inhibitors with low-micromolar potency, PHT-39, which carries a trifluoromethyl substitution, demonstrated the highest efficacy in the intramacrophage assay, with an EC50 of 1.2 +/- 3.2 μM. Cytotoxicity testing of PHT-39 in HepG2 cells indicated a promising selectivity of over 90-fold. A chemogenomic profiling approach was conducted using an orthology-based method to elucidate the mode of action of PHT-39. This genome-wide RNA interference library of T. brucei identified sensitivity determinants for PHT-39, which included a P-type ATPase that is crucial for the uptake of miltefosine and amphotericin, strongly indicating a shared route for cellular entry. Notwithstanding the favourable properties and demonstrated efficacy in the Plasmodium berghei infection model, PHT-39 was unable to eradicate L. major infection in a murine infection model of cutaneous leishmaniasis. Currently, PHT-39 is undergoing derivatization to optimize its pharmacological characteristics.
650    _2
$a lidé $7 D006801
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a antiprotozoální látky $x farmakologie $x terapeutické užití $7 D000981
650    12
$a Leishmania $7 D007891
650    _2
$a amfotericin B $x terapeutické užití $7 D000666
650    12
$a leishmanióza kožní $x parazitologie $7 D016773
650    _2
$a ftalimidy $x farmakologie $x terapeutické užití $7 D010797
650    12
$a Leishmania infantum $7 D018314
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bansal, Meenakshi $u H. G. Khorana Centre for Chemical Biology, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India $u Department of Chemistry, Deenbandhu Chhotu Ram, University of Science & Technology, Murthal, Sonepat Haryana, India
700    1_
$a Sharma, Neha $u H. G. Khorana Centre for Chemical Biology, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India
700    1_
$a Kumar, Sumit $u Department of Chemistry, Deenbandhu Chhotu Ram, University of Science & Technology, Murthal, Sonepat Haryana, India
700    1_
$a Shen, Siqi $u Drug Discovery and Evaluation Unit, Department of Parasitology, Faculty of Science, Charles University in Prague, Biocev, Vestec, Czech Republic
700    1_
$a Singh, Priyamvada $u Department of Chemistry, Miranda House, University of Delhi, Delhi, India $u Delhi School of Public Health, Institution of Eminence, University of Delhi, Delhi, India
700    1_
$a Rathi, Brijesh $u H. G. Khorana Centre for Chemical Biology, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India $u Delhi School of Public Health, Institution of Eminence, University of Delhi, Delhi, India
700    1_
$a Zoltner, Martin $u Drug Discovery and Evaluation Unit, Department of Parasitology, Faculty of Science, Charles University in Prague, Biocev, Vestec, Czech Republic $1 https://orcid.org/000000020214285X
773    0_
$w MED00165375 $t PLoS neglected tropical diseases $x 1935-2735 $g Roč. 18, č. 3 (2024), s. e0012050
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38527083 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134057 $b ABA008
999    __
$a ok $b bmc $g 2143981 $s 1226409
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 18 $c 3 $d e0012050 $e 20240325 $i 1935-2735 $m PLoS neglected tropical diseases $n PLoS Negl Trop Dis $x MED00165375
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

    Možnosti archivace